Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Novel Biomarkers and Echocardiography to Assess Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines

NCT03155802 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT03155802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03155802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Novel Biomarkers and Echocardiography to Assess Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines
Lead sponsor
Stony Brook University
Phase
Observational
Overall status
Unknown status
Start date
April 18, 2017
Completion date
December 31, 2020
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anthracycline induced cardiomyopathy, biomarkers, breast cancer, cardiotoxicity, echocardiography, heart failure